Browsing by Author "Azemraw, Temesgen"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    COVID-19 vaccine hesitancy and its determinants among Sub-Saharan African adolescents
    (PLOS, 2022) Wang, Dongqing; Chukwu, Angela; Mwanyika-Sando, Mary; Abubakar, Sulemana Watara; Assef, Nega; Madzorera, Isabel; Hemler, Elena C.; Ismai, Abbas; Lankoande, Bruno; Mapendo, Frank; Millogo, Ourohire´; Workneh, Firehiwot; Azemraw, Temesgen; Febir, Lawrence Gyabaa; James, Christabel; Tinkasimile, Amani; Asant, Kwaku Poku; Baernighausen, Till; Berhane, Yemane; Killewo, Japhet; Oduola, Ayoade M. J.; Sie, Ali; Smith, Emily R.; Soura, Abdramane Bassiahi; Raj, Tajudeen; Vuai, Said; Fawzi, Wafaie W.
    COVID-19 vaccine hesitancy among adolescents poses a challenge to the global effort to control the pandemic. This multi-country survey aimed to assess the prevalence and determinants of COVID-19 vaccine hesitancy among adolescents in sub-Saharan Africa between July and December 2021. The survey was conducted using computer-assisted telephone interviewing among adolescents in five sub-Saharan African countries, Burkina Faso, Ethiopia, Ghana, Nigeria, and Tanzania. A rural area and an urban area were included in each country (except Ghana, which only had a rural area), with approximately 300 adolescents in each area and 2662 in total. Sociodemographic characteristics and perceptions and attitudes on COVID-19 vaccines were measured. Vaccine hesitancy was defined as definitely not getting vaccinated or being undecided on whether to get vaccinated if a COVID-19 vaccine were available. Log-binomial models were used to calculate the adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) for associations between potential determinants and COVID-19 vaccine hesitancy. The percentage of COVID-19 vaccine hesitancy was 14% in rural Kersa, 23% in rural Ibadan, 31% in rural Nouna, 32% in urban Ouagadougou, 37% in urban Addis Ababa, 48% in rural Kintampo, 65% in urban Lagos, 76% in urban Dar es Salaam, and 88% in rural Dodoma. Perceived low necessity, concerns about vaccine safety, and concerns about vaccine effectiveness were the leading reasons for hesitancy. Healthcare workers, parents or family members, and schoolteachers had the greatest impacts on vaccine willingness. Perceived lack of safety (aPR: 3.52; 95% CI: 3.00, 4.13) and lack of effectiveness (aPR: 3.46; 95% CI: 2.97, 4.03) were associated with greater vaccine hesitancy. The prevalence of COVID-19 vaccine hesitancy among adolescents is alarmingly high across the five sub-Saharan African countries, especially in Tanzania. COVID-19 vaccination campaigns among sub-Saharan African adolescents should address their concerns and misconceptions about vaccine safety and effectiveness.
  • Thumbnail Image
    Item
    Determinants of COVID-19 vaccine readiness and hesitancy among adults in sub-Saharan Africa
    (PLOS Global Public Healt, 2023) Abubakari, Sulemana Watara; Workneh, Firehiwot; Asante, Kwaku Poku; Hemler, Elena C.; Madzorera, Isabel; Wang, Dongqing; Ismai, Abbas; Nega Assefa; Azemraw, Temesgen; Lankoande, Bruno; Nuhu, Abdul Razak; Chukwu, Angela; Mapendo, Frank; Millogo, Ourohiré; Olufemi, Adedokun A.; Okpara, Daniel; Boudo, Valentin; Mwanyika-Sando, Mary; Berhane, Yemane; Baernighause, Till; Oduola, Ayoade; Vuai, Said; Sie, Ali; Soura, Abdramane; Killewo, Japhet; Tajudeen, Raji; Fawz, Wafaie W.; Smith, Emily R.
    There is very limited data on the extent and determinants of COVID-19 vaccine hesitancy among adults living in sub-Saharan Africa since the global roll-out of vaccines began in 2021. This multi-country survey sought to investigate COVID-19 vaccine hesitancy and other predictors of readiness to get vaccinated. We conducted surveys among adults residing in nine urban and rural areas in Burkina Faso, Ethiopia, Ghana, Nigeria, and Tanzania in late 2021. Log binomial regression models were used to identify prevalence and factors associated with vaccine hesitancy and beliefs around COVID-19 misinformation. We completed a total of 2,833 interviews. Among all respondents, 9% had never heard of a COVID-19 vaccine, 12% had been vaccinated, and 20% knew someone else who had been vaccinated. The prevalence of vaccine hesitancy varied by country (Ethiopia 29%, Burkina Faso 33%, Nigeria 34%, Ghana 42%, Tanzania 65%), but not by rural or urban context. People who did not think the vaccine was safe or effective, or who were unsure about it, were more likely to be vaccine hesitant. Those who reported they did not have a trusted source of information about the vaccine (aPR: 1.25, 95% CI: 1.18,1.31) and those who thought the vaccine would not be made available to them within the year were more likely to be vaccine hesitant. Women were more likely to be vaccine hesitant (aPR: 1.31, 95% CI: 1.19,1.43) and believe COVID-19 falsehoods (aPR: 1.05, 95% CI: 1.02,1.08). The most commonly believed falsehoods were that the vaccine was developed too fast and that there was not enough information about whether the vaccine was effective or not. Educational campaigns targeted at misinformation and tailored to suit each country are recommended to build trust in COVID-19 vaccines and reduce hesitancy.